Using cell function assays, we uncovered that let-7g-5p inhibits the oncogenic role of IGF2BP3 in tumor progression, and regulates the activity of the KLK5/PAR2/AKT axis in GBC. The gene discussed is F2RL1; the disease is neoplasm.